Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Article

AJVS. 2017; 54(1): 149-157


Cytokines Evaluation of Different Marek's Disease Virus Vaccines in Broiler Chickens

Leila K. Abdelhamid, Helmy A. Torky, Samy A. Khalil.

Abstract
Marek's disease is an immune suppressive disease that threatens poultry industry. It is controlled by vaccination against MDV. However, the post-vaccination immune mechanisms remain vague. Therefore, the objective of this study was to examine the transcripts of the cellular immune responses of two commercial vaccines (CVI988 and HVT strains) compared to control non-vaccinated chickens through the analyses of several cytokine responses. The mRNA was extracted from the bursa of Fabricius and thymus, sampled at 7, 14 and 21 days post-immunization (PI) of both vaccinated and control groups. Several pro-inflammatory and anti-inflammatory cytokine gene expressions were analyzed using RT-PCR. Early significant up-regulation of IFN-γ, a pro-inflammatory cytokine was observed. Also, upregulation of other cytokines like IL-1β and IL-6 was observed at different time points along with minimal non-significant expression of inducible nitric oxide synthase (iNOS) in both of vaccinated groups. Meanwhile, a late upregulation of the anti-inflammatory cytokine, IL-10 was only noticed by 21 day PI. These findings show that both vaccinal strains mimic the natural infection by inducing early cell-mediated inflammatory responses, while devoid the long-term immune suppressive effect of natural infection. Additionally, vaccination triggers anti-tumor cell-mediated responses as indicated by the late increase of IL-10 expression. Furthermore, the observed cytokine responses following CV1988 strain supports its previously reported efficacy over HVT strain, making the Rispens vaccine more suitable candidate for Egyptian field conditions. Additionally, the early observed up-regulation of IFN-γ cytokine nominates its administration as an adjuvant with the Rispens vaccine; this may provide synergistic immunomodulatory capacities to the available vaccines and better levels of protection.

Key words: Marek's disease vaccines, Pro-inflammatory Cytokines, RT-PCR, Chicken



Similar Articles

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends.
Zhang H, Elefant F
Neural regeneration research. 2022; 17(2): 325-327

Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era.
Tantisattamo E, Hanna RM, Kalantar-Zadeh K
Current opinion in nephrology and hypertension. 2022; 31(1): 1-5

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Differentiating Human Pluripotent Stem Cells to Vascular Endothelial Cells for Regenerative Medicine, Tissue Engineering, and Disease Modeling.
Bertucci T, Kakarla S, Kim D, Dai G
Methods in molecular biology (Clifton, N.J.). 2022; 2375(): 1-12

Presenilin mutations and their impact on neuronal differentiation in Alzheimer's disease.
Hernandez-Sapiens MA, Reza-Zaldívar EE, Márquez-Aguirre AL, Gómez-Pinedo U, Matias-Guiu J, Cevallos RR, Mateos-Díaz JC, Sánchez-González VJ, Canales-Aguirre AA
Neural regeneration research. 2022; 17(1): 31-37


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites